Calendar of CURE/Yale BioHaven seminars for Fall 2010 now available. more9/14
8:45 am - 6:00 pmUbifrance, the French Agency for international business development, cordially invites CURE members to this year's second French Biotech Tour, which aims to connect French and American Biotech companies specialized in neuroscience, inflammation, and auto-immune diseases. Philadelphia, PA. more
9/16
6:00 pm - 7:30 pmCURE/Yale BioHaven presents Al Mann: 'Creating a successful medical device enterprise.' Hope Auditorium, Yale University, 315 Cedar Street, New Haven. more
10/5Deadline for nominations for the Lemelson-MIT prize, awarded to an outstanding mid-career inventor who has developed a patented product or process of significant value to society. more
10/14
4:00 pm - 7:00 pmHartford Hospital Research Symposium. 'Personalized Medicine and Genomics: The Future is Now.' RSVP by 10/1 to 860.545.5620. Heublein Hall, Education & Resource Center, Hartford Hospital, Hudson Street, Hartford. more
10/27
4:00 pm - 6:00 pmCURE/Yale BioHaven presents Cobalt Therapeutics. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
11/18
4:00 pm - 6:00 pmCURE/Yale BioHaven presents Biodel Inc. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
12/7
5:30 pm - 7:30 pm
CURE Holiday Party. Café George, 300 George Street, New Haven. Watch for details.
|
Applied Spine Technologies, Inc.
300 George Street, Suite 511
New Haven, CT 06511
Phone: 203-503-0280
Fax: 203-503-0282
Website: http://www.appliedspine.com
Contact(s)
Alexis Stellner
-
astellner@appliedspine.com
General Information
Applied Spine Technologies (AST), Inc. has developed a novel dynamic stabilization system, marketed under the Stabilimax brand that leverages the 30-plus years of spine biomechanical experience and concepts developed by Dr. Manohar Panjabi, our Scientific Founder from Yale University. The Stabilimax NZ® system was developed to work in concert with the spine’s natural biomechanics resulting in a stabilization device that will address the patient’s pain while allowing normal physiological motion. AST has performed extensive lab testing as well as numerous cadaveric and animal studies to validate the device, and we are now well into our pivotal IDE trial.
Other Information
CT Employees: 18
Back
|
